A case of aripiprazole-associated paroxysmal supraventricular tachycardia

Journal of Clinical Psychopharmacology

Volumn 29, Issue 5, 2009, Pages 506-508

  Tsai, Pei Chen ^a   Hsiao, Shih Hung ^b,c   Chiu, Chih Chiang ^d  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BIPERIDEN; FLUPENTIXOL; LORAZEPAM; PROPRANOLOL; RISPERIDONE;

ADULT; BIPOLAR I DISORDER; CASE REPORT; CHEST TIGHTNESS; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FOLLOW UP; GRANDIOSE DELUSION; HEART RATE; HOSPITALIZATION; HUMAN; IRRITABILITY; LETTER; MALE; OCULOGYRIC CRISIS; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; PSYCHOSIS; THORAX PAIN;

ELECTROCARDIOGRAPHY; HUMANS; MALE; PIPERAZINES; QUINOLONES; TACHYCARDIA, SUPRAVENTRICULAR; YOUNG ADULT;

EID: 70349686453     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181b675ba     Document Type: Letter

References (10)

1. Taylor DM. Aripiprazole: A review of its pharmacology and clinical use. Int J Clin Pract. 2003;63:49-54.
2. Smith LA, Cornelius V, Warnock A, et al. Pharmacological interventions for acute bipolar mania: A systemic review of randomized placebo-controlled trials. Bipolar Disord. 2007;9:551-560.
3. Ikawa M, Tabuse H, Ueno S, et al. Effects of combination psychotropic drug treatment on heart rate variability in psychiatric patients. Psychiatry Clin Neurosci. 2001;55(4):341-345.
4. McEvoy JP, Daniel DG, Carson WH Jr, et al. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. J Psychiatr Res. 2007;41:895-905.
5. Egger C, Rauscher A, Muehlbacher M, et al. A case of dose-dependent aripiprazole induced conduction disturbance. J Clin Psychopharmacol. 2006;26:436.
6. Torgovnick J, Sethi NK, Arsura E. Aripiprazole-induced orthostatic hypotension and cardiac arrhythmia. Psychiatry Clin Neurosci. 2008;62:485.
7. Hayes JJ, Sharma PP, Smith PN, et al. Familial atrioventricular nodal reentry tachycardia. Pacing Clin Electrophysiol. 2004;27(1):73-76.
8. Chiou CW, Chen SA, Kung MH, et al. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways. Circulation. 2003;107(20): 2583-2588.
9. Mannens G, Huang ML, Meuldermans W, et al. Absorption, metabolism, and excretion of risperidone in humans. Drug Metab Dispos. 1993;21(6):1134-1141.
10. Kim JR, Seo HB, Cho JY, et al. Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients. Br J Clin Pharmacol. 2008;66(6):802-810.